JP Patent

JP5000649B2 — 甲状腺ホルモン受容体アゴニストとしてのピリダジノン誘導体

Assigned to F Hoffmann La Roche AG · Expires 2012-08-15 · 14y expired

What this patent protects

Patent listed against resmetirom.

Drugs covered by this patent

Patent Metadata

Patent number
JP5000649B2
Jurisdiction
JP
Classification
—
Expires
2012-08-15
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.